Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M. Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilippNosha Farhadfar, Shahinaz Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard Hildebrandt, Christopher G. Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell Krem, Hillard Lazarus, Hongtao Liu, Rodrigo Martino, Fotios V. Michelis, Sunita Nathan, Taiga Nishihori, Richard Olsson, Ran Reshef, David Rizzieri, Jacob M. Rowe, Bipin N. Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, Christopher Hourigan, Brenda Sandmaier, Mark Litzow, Partow Kebriaei, Daniel Weisdorf, Yanming Zhang, Martin S. Tallman, Wael Saber

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML'. Together they form a unique fingerprint.

Medicine & Life Sciences